State of the art: Contrast agents for mr imaging of the liver

Radiology

Volumn 218, Issue 1, 2001, Pages 27-38

  Semelka, R C ^a   Helmberger, T K G ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CONTRAST MEDIUM; GADOLINIUM; IRON OXIDE;

ARTICLE; CONTRAST ENHANCEMENT; CONTRAST RADIOGRAPHY; DIAGNOSTIC IMAGING; HUMAN; INTERMETHOD COMPARISON; LIVER DISEASE; LIVER TUMOR; NUCLEAR MAGNETIC RESONANCE IMAGING; PARTICULATE MATTER; PRIORITY JOURNAL; RETICULOENDOTHELIAL SYSTEM; SIGNAL DETECTION; THREE DIMENSIONAL IMAGING; COMPARATIVE STUDY; COMPUTER ASSISTED TOMOGRAPHY; LIVER CELL; METHODOLOGY; PATHOLOGY; PERFUSION; REVIEW;

CONTRAST MEDIA; HEPATOCYTES; HUMANS; LIVER DISEASES; MAGNETIC RESONANCE IMAGING; PERFUSION; RETICULOENDOTHELIAL SYSTEM; TOMOGRAPHY, X-RAY COMPUTED;

EID: 0035226882     PISSN: 00338419     EISSN: None     Source Type: Journal    
DOI: 10.1148/radiology.218.1.r01ja2427     Document Type: Article

References (59)

1. Comparison of breath-hold T1-weighted MR sequences for imaging of the liver
2. Abdominal MR imaging with a volumetric interpolated breath-hold examination
3. Liver
4. Malignant lesions of the liver with high signal intensity on T1-weighted MR images
5. Abdominal MR imaging: Comparison of T2-weighted fast conventional spin-echo, and contrast-enhanced fast multiplanar spoiled gradient-recalled imaging
6. Islet cell tumors: Comparison of dynamic contrast-enhanced CT and MR imaging with dynamic gadolinium enhancement and fat suppression
7. Hypervascular malignant liver lesions: Comparison of various MR imaging pulse sequences and dynamic CT
8. Liver lesion detection, characterization, and effect on patient management: Comparison of single-phase spiral CT and current MR techniques
9. Focal liver disease: Comparison of dynamic contrast-enhanced CT and T2-weighted fat-suppressed, FLASH, and dynamic gadolinium-enhanced MR imaging at 1.5 T
10. Extrahepatic abdominal imaging in patients with malignancy: Comparison of MR imaging and helical CT, with subsequent surgical correlation
11. Evaluation of a 10-minute comprehensive MR imaging examination of the upper abdomen
12. Dynamic MR imaging and early-phase helical CT for detection small of intrahepatic metastases of hepatocellular carcinoma
13. Small hepatocellular carcinoma in patients with chronic liver damage: Prospective comparison of detection with dynamic MR imaging and helical CT of the whole liver
14. Solitary hepatic metastasis: Comparison of dynamic contrast-enhanced CT and MR imaging with fat-suppressed T2-weighted, breath-hold T1-weighted FLASH, and dynamic gadolinium-enhanced FLASH sequences
15. Dynamic breath-hold multiplanar spoiled gradient-recalled MR imaging with gadolinium enhancement for differentiating hepatic hemangiomas from malignancies at 1.5 T
16. Hypervascular liver lesions: Differentiation of focal nodular hyperplasia from malignant tumors with dynamic gadolinium-enhanced MR imaging
17. Hepatic arterial-phase dynamic gadolinium-enhanced MR imaging: Optimization with a test examination and a power injector
18. Focal liver lesions: Characterization with nonenhanced and dynamic contrast material-enhanced MR imaging
19. Spin-echo and dynamic gadolinium-enhanced FLASH MR imaging of hepatocellular carcinoma: Correlation with histopathologic findings
20. Small hepatocellular carcinoma and cavernous hemangioma; differentiation with dynamic FLASH MR imaging with Gd-DTPA
21. Focal hepatic lymphoma: Magnetic resonance demonstration using current techniques including gadolinium enhancement
22. Pyogenic hepatic abscesses: MRI findings on T1- and T2-weighted serial gadolinium-enhanced gradient-echo image
23. Hepatic hemangiomas: A multi-institutional study of appearance of T2-weighted and serial gadolinium-enhanced gradient-echo MR images
24. Transient increased segmental hepatic enhancement distal to portal vein obstruction on dynamic gadolinium-enhanced gradient echo MR images
25. Correlation of perfusion abnormalities on CTAP and immediate postintravenous gadolinium-enhanced gradient echo MRI
26. Ultrasound and MR findings in acute Budd-Chiari syndrome with histopathologic correlation
27. Budd-Chiari syndrome: Spectrum of appearances of acute, subacute, and chronic disease with magnetic resonance imaging
28. Quantitative MR imaging data in the evaluation of hepatic metastases during systemic chemotherapy
29. Angiosarcoma of the liver: MR imaging pre- and post-chemotherapy
30. Chemotherapy-treated liver metastases mimicking hemangiomas on MR images
31. Focal nodular hyperplasia of the liver: Assessment with contrast-enhanced Turbo-FLASH MR imaging
32. Peripheral washout: A sign of malignancy on dynamic gadolinium-enhanced MR images of focal liver lesions
33. Evaluation of malignant biliary obstruction: Efficacy of fast multiplanar spoiled gradient-recalled MR imaging vs. spin-echo MR imaging, CT and cholangiography
34. MR imaging of peritoneal disease: Comparison of contrast enhanced fast multiplanar spoiled gradient-recalled and spin-echo imaging
35. Cholangiocarcinoma: Spectrum of appearances on MR images using current techniques
36. Renal lesion characterization with gadolinium-enhanced MR imaging: Efficacy and safety in patients with renal insufficiency
37. Hepatic metastases: CT versus MR imaging at 1.5 T
38. Malignant liver lesions: Comparison of spiral CT arterial portography and MR imaging for diagnostic accuracy, cost, and effect on patient management
39. Detection of liver metastases: Comparison of superparamagnetic iron oxide-enhanced and unenhanced MR imaging at 1.5 T with dynamic CT, intraoperative US, and percutaneous US
40. Detection of hepatic metastases: Ferumoxides-enhanced MR imaging versus unenhanced MR imaging and CT during arterial portography
41. Hepatic lesion detection: Comparison of MR imaging after the administration of superparamagnetic iron oxide with dual-phase CT by using alternative-free response receiver operating characteristic analysis
42. Ovarian cancer: Comparison of findings with perfluorocarbon-enhanced MR imaging, In-111-SYT-103 immunoscintigraphy, and CT
43. Renal canker staging: Comparison of contrast-enhanced CT and gadolinium-enhanced fat-suppressed spin-echo and gradient-echo MR imaging
44. Hepatic MR imaging with ferumoxides: A multicenter clinical trial of the safety and efficacy in the detection of focal hepatic lesions
45. Hepatic lesions: Detection with ferumoxide-enhanced T1-weighted MR imaging
46. Hepatic lesion detection at MR imaging: A comparative study with four sequences
47. Clinical results with Resovist: A phase 2 clinical trial
48. Differentiation of hepatomas from nonhepatomatous masses: Use of MnDPDP-enhanced MR images
49. Diagnostic efficiency of Mn-DPDP in MR imaging of the liver: A phase III multicenter study
50. Mangafodipir trisodium: Effects on T2- and T1-weighted MR cholangiography
51. Focal malignant liver lesions: MR imaging enhanced with gadolinium benzoxypropionictetra-acetate (BOPTA) - Preliminary results of phase II clinical application
52. Phase I clinical evaluation of Gd-EOB-DTPA as a hepatobiliary MR contrast agent: Safety, pharmacokinetics, and MR imaging
53. Liver tumors: Comparison of MR imaging with Gd-EOB-DTPA and Gd-DTPA
54. Comparison of gadolinium with manganese-DPDP for liver lesion detection and characterization: Preliminary results
55. Superparamagnetic iron oxide-enhanced versus gadolinium-enhanced MR imaging for differential diagnosis of focal liver lesions
56. MR imaging properties and pharmacokinetics of MnDPDP in healthy volunteers
57. Safety and pharmacokinetic profile of gadobenate dimeglumine in subjects with renal impairment
58. Pharmacokinetics of the liver-specific contrast agent Gd-EOB-DTPA in relation to contrast-enhanced liver imaging in humans
59. Safety, tolerance, biodistribution, and MR imaging enhancement of the liver with gadobenate dimeglumine: Results of clinical pharmacologic and pilot imaging studies in nonpatient and patient volunteers